Handgrip Training in Patients With Peripheral Artery Disease
Effects of 12 Weeks of Isometric Handgrip Training in Blood Pressure in Patients With Peripheral Artery Disease
University of Nove de Julho
30 participants
Aug 1, 2018
INTERVENTIONAL
Conditions
Summary
The aim of this study is to analyze the effects of isometric handgrip training (IHT) on blood pressure of hypertensive patients with peripheral arterial disease. Will be recruited 30 patients which will be randomized into 2 groups (15 per group), IHT and control group (CG). IHT group will training isometric contraction for 12 weeks. In CG patients will be encouraged to increase the level of physical activity. In the pre and post-intervention cardiovascular measures will be obtained.
Eligibility
Inclusion Criteria5
- Women in post-menopause phase without hormone replacement therapy
- Ankle-brachial index <0.90
- Not severe obese (≥ 35kg/m2)
- Not present amputation in the limbs
- Have blood pressure levels lower than 160mmHg for systolic and 105mmHg for diastolic
Exclusion Criteria1
- patients will only be excluded if they make any medication changes before completing the intervention period or present any health problems that prevent physical activity.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Intervention period will last 12 weeks. Experimental group will perform three sessions per week of home-based handgrip exercise. The exercise protocol will consist of eight sets of bilateral handgrip contraction of two minutes of isometric contraction, with 30% of maximum voluntary contraction, and two minutes of interval between sets. Patients will receive a diary to record the sessions and report difficulties during the training. The patients be recommended to increase daily physical activity levels, and weekly, there will be phone contacts with the patients to reinforce the exercise recommendations.
Intervention period will last 12 weeks. Patients will be recommended to increase daily physical activity levels, and weekly, there will be phone contacts to reinforce the recommendations.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03663777